Breast Cancer and Breast Health

Episodes 1-11 of 11

• 

  RestartResume

  Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC

  RestartResume

  Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC

  MinuteCE®

  Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC

  1.00 program credit

  • 

    

    Egbert Smit, MD

  1.00 program credit

• 

  RestartResume

  ADC-Related Hematologic Adverse Events

  RestartResume

  ADC-Related Hematologic Adverse Events

  MinuteCE®

  ADC-Related Hematologic Adverse Events

  1.00 program credit

  • 

    

    Egbert Smit, MD

  1.00 program credit

• 

  RestartResume

  ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities 

  RestartResume

  ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities 

  MinuteCE®

  ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities 

  1.00 program credit

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit

• 

  RestartResume

  Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer 

  RestartResume

  Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer 

  MinuteCE®

  Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer 

  1.00 program credit

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit

• 

  MinuteCE®

  Mastering the AEs of ADCs to Unlock Their Full Potential in Breast, Lung, and Gynecologic Cancer

  1.00 credit 10 episodes

  • 

    

    Nadia Harbeck, MD, PhD

  • 

    

    Egbert Smit, MD

  • 

    

    Susana Campos, MD, MPH

  1.00 credit 10 episodes

• 

  RestartResume

  Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers

  RestartResume

  Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers

  MinuteCE®

  Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers

  1.00 program credit

  • 

    

    Susana Campos, MD, MPH

  1.00 program credit

• 

  RestartResume

  Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies

  RestartResume

  Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies

  MinuteCE®

  Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies

  1.00 program credit

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit

• 

  RestartResume

  ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs

  RestartResume

  ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs

  MinuteCE®

  ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs

  1.00 program credit

  • 

    

    Susana Campos, MD, MPH

  1.00 program credit

• 

  RestartResume

  Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials

  RestartResume

  Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials

  MinuteCE®

  Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials

  1.00 program credit

  • 

    

    Egbert Smit, MD

  1.00 program credit

• 

  RestartResume

  Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC

  RestartResume

  Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC

  MinuteCE®

  Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC

  1.00 program credit

  • 

    

    Egbert Smit, MD

  1.00 program credit

• 

  RestartResume

  Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer

  RestartResume

  Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer

  MinuteCE®

  Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer

  1.00 program credit

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit